256 related articles for article (PubMed ID: 27638745)
21. Long-term impact of myocardial inflammation on quantitative myocardial perfusion-a descriptive PET/MR myocarditis study.
Buechel RR; Ciancone D; Bakula A; von Felten E; Schmidt GA; Patriki D; Gräni C; Wahl A; Manka R; Heidecker B; Benz DC; Giannopoulos AA; Pazhenkottil AP; Kaufmann PA
Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3609-3618. PubMed ID: 37391545
[TBL] [Abstract][Full Text] [Related]
22. Performance of cardiac PET/CT with and without phase analysis for detection of scar in cardiac sarcoidosis: Comparison to cardiac magnetic resonance imaging.
Elwazir MY; Bird JG; AbouEzzeddine OF; Chareonthaitawee P; Blauwet LA; Collins JD; Gibbons RJ; Rodriguez-Porcel M; Kamal HM; Abdellah AT; Bois JP
J Nucl Cardiol; 2022 Jun; 29(3):1389-1401. PubMed ID: 33474694
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Value of Cardiac MRI and FDG PET in Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis.
Aitken M; Davidson M; Chan MV; Urzua Fresno C; Vasquez LI; Huo YR; McAllister BJ; Broncano J; Thavendiranathan P; McInnes MDF; Iwanochko MR; Balter M; Moayedi Y; Farrell A; Hanneman K
Radiology; 2023 Apr; 307(2):e222483. PubMed ID: 36809215
[TBL] [Abstract][Full Text] [Related]
24. Comparative Analysis of Myocardial Viability Multimodality Imaging in Patients with Previous Myocardial Infarction and Symptomatic Heart Failure.
Kazakauskaite E; Vajauskas D; Unikaite R; Jonauskiene I; Virbickiene A; Zaliaduonyte D; Lapinskas T; Jurkevicius R
Medicina (Kaunas); 2022 Mar; 58(3):. PubMed ID: 35334543
[TBL] [Abstract][Full Text] [Related]
25. Assessment of Myocarditis: Cardiac MR, PET/CT, or PET/MR?
Chen W; Jeudy J
Curr Cardiol Rep; 2019 Jun; 21(8):76. PubMed ID: 31243587
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of FDG PET combined with cardiac MRI for the diagnosis and therapeutic monitoring of cardiac sarcoidosis.
Sgard B; Brillet PY; Bouvry D; Djelbani S; Nunes H; Meune C; Valeyre D; Soussan M
Clin Radiol; 2019 Jan; 74(1):81.e9-81.e18. PubMed ID: 30482560
[TBL] [Abstract][Full Text] [Related]
27. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
[TBL] [Abstract][Full Text] [Related]
28. Combined simultaneous FDG-PET/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis.
Cheung E; Ahmad S; Aitken M; Chan R; Iwanochko RM; Balter M; Metser U; Veit-Haibach P; Billia F; Moayedi Y; Ross HJ; Hanneman K
Eur J Hybrid Imaging; 2021 Dec; 5(1):24. PubMed ID: 34913098
[TBL] [Abstract][Full Text] [Related]
29. Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.
Rischpler C; Dirschinger RJ; Nekolla SG; Kossmann H; Nicolosi S; Hanus F; van Marwick S; Kunze KP; Meinicke A; Götze K; Kastrati A; Langwieser N; Ibrahim T; Nahrendorf M; Schwaiger M; Laugwitz KL
Circ Cardiovasc Imaging; 2016 Apr; 9(4):e004316. PubMed ID: 27056601
[TBL] [Abstract][Full Text] [Related]
30. Downstream indication to revascularization following hybrid cardiac PET/MRI: preliminary results.
Priamo J; Adamopoulos D; Rager O; Frei A; Noble S; Carballo D; Ratib O; Nkoulou R
Nucl Med Commun; 2017 Jun; 38(6):515-522. PubMed ID: 28430739
[TBL] [Abstract][Full Text] [Related]
31. Image fusion between 18F-FDG PET and MRI in cardiac sarcoidosis: A case series.
Zandieh S; Bernt R; Mirzaei S; Haller J; Hergan K
J Nucl Cardiol; 2018 Aug; 25(4):1128-1134. PubMed ID: 27604109
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic performance of
Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
34. Combined Cardiac Fluorodeoxyglucose-Positron Emission Tomography/Magnetic Resonance Imaging Assessment of Myocardial Injury in Patients Who Recently Recovered From COVID-19.
Hanneman K; Houbois C; Schoffel A; Gustafson D; Iwanochko RM; Wintersperger BJ; Chan R; Fish JE; Howe KL; Thavendiranathan P
JAMA Cardiol; 2022 Mar; 7(3):298-308. PubMed ID: 35019953
[TBL] [Abstract][Full Text] [Related]
35.
Linder G; Korsavidou-Hult N; Bjerner T; Ahlström H; Hedberg J
Clin Radiol; 2019 Sep; 74(9):718-725. PubMed ID: 31221468
[TBL] [Abstract][Full Text] [Related]
36. Clinical Utility of Combined FDG-PET/MR to Assess Myocardial Disease.
Abgral R; Dweck MR; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Padilla M; Miller M; Lala A; Sanz J; Narula J; Fuster V; Contreras J; Kovacic JC; Fayad ZA
JACC Cardiovasc Imaging; 2017 May; 10(5):594-597. PubMed ID: 27372018
[No Abstract] [Full Text] [Related]
37. Progressing Toward a Cohesive Pediatric 18F-FDG PET/MR Protocol: Is Administration of Gadolinium Chelates Necessary?
Klenk C; Gawande R; Tran VT; Leung JT; Chi K; Owen D; Luna-Fineman S; Sakamoto KM; McMillan A; Quon A; Daldrup-Link HE
J Nucl Med; 2016 Jan; 57(1):70-7. PubMed ID: 26471690
[TBL] [Abstract][Full Text] [Related]
38. Hybrid Positron Emission Tomography/Magnetic Resonance Imaging in Arrhythmic Mitral Valve Prolapse.
Miller MA; Adams DH; Pandis D; Robson PM; Pawale A; Pyzik R; Liao SL; El-Eshmawi A; Boateng P; Garg J; Waterford S; Weiner MM; Dukkipati SR; Reddy VY; Fayad ZA; Trivieri MG
JAMA Cardiol; 2020 Sep; 5(9):1000-1005. PubMed ID: 32936270
[TBL] [Abstract][Full Text] [Related]
39. Imaging of myocardial inflammation with somatostatin receptor based PET/CT - A comparison to cardiac MRI.
Lapa C; Reiter T; Li X; Werner RA; Samnick S; Jahns R; Buck AK; Ertl G; Bauer WR
Int J Cardiol; 2015 Sep; 194():44-9. PubMed ID: 26005805
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic Accuracy of Cardiac MRI versus FDG PET for Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis.
Aitken M; Chan MV; Urzua Fresno C; Farrell A; Islam N; McInnes MDF; Iwanochko M; Balter M; Moayedi Y; Thavendiranathan P; Metser U; Veit-Haibach P; Hanneman K
Radiology; 2022 Sep; 304(3):566-579. PubMed ID: 35579526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
